


Update of the Diagnostic Panel for Cardiac Diseases: New overarching gene set for cardiac arrhythmias
The Diagnostic Panel for Cardiac Disease has been revised based…

New CancerPrecision® Report including a Graphical Representation of Results and Detailed Information on Applicable Drugs
CeGaT’s new tumor report has been completely revised and raised…

Update of the Diagnostics Panel for Connective Tissue Diseases: New diagnostics for VISS syndrome and expanded diagnostics for cutis laxa and familial TAAD
The Diagnostic Panel for Connective Tissue Diseases has been…

Watch Our Free Webinar and Learn How We Can Help You Solve Complex Patient Cases
Many patients show nonspecific and complex clinical pictures.…


New Exome Diagnostics: ExomeFocus® – Cost-Effective and Fast Results
CeGaT has adapted its in-house exome diagnostics and revised…

Explore DNA Methylation on a Genome-Wide Scale
CeGaT expands its Research and Pharma Solutions product portfolio…

Genetic Diagnostics
Research & Pharma Solutions

CeGaT is a provider of genetic diagnostics and NGS services. The company is based in Tübingen, Germany and is accredited according to CAP, CLIA, DIN EN ISO 15189 and DIN EN ISO 17025.